Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/181514
Title: DABCO-Customized Nanoemulsions: Characterization, Cell Viability and Genotoxicity in Retinal Pigmented Epithelium and Microglia Cells
Author: Fernandes, Ana Rita
Dos Santos, Tiago
Granja, Pedro L.
Sánchez-López, E. (Elena)
Santini, Antonello
García López, María Luisa
Silva, Amélia M.
Souto, Eliana B.
Keywords: Emulsions (Farmàcia)
Nanofluids
Farmacologia ocular
Nanociència
Emulsions (Pharmacy)
Nanofluids
Ocular pharmacology
Nanoscience
Issue Date: 10-Oct-2021
Publisher: MDPI
Abstract: Quaternary derivatives of 1,4-diazabicyclo[2.2.2]octane (DABCO) and of quinuclidine surfactants were used to develop oil-in-water nanoemulsions with the purpose of selecting the best long-term stable nanoemulsion for the ocular administration of triamcinolone acetonide (TA). The combination of the best physicochemical properties (i.e., mean droplet size, polydispersity index, zeta potential, osmolality, viscoelastic properties, surface tension) was considered, together with the cell viability assays in ARPE-19 and HMC3 cell lines. Surfactants with cationic properties have been used to tailor the nanoemulsions' surface for site-specific delivery of drugs to the ocular structure for the delivery of TA. They are tailored for the eye because they have cationic properties that interact with the anionic surface of the eye. Keywords: cationic nanoemulsions, DABCO surfactants, quinuclidine surfactants, ocular administration, triamcinolone acetonide, age-related macular degeneration, HMC3 cell line, ARPE-19 cell line
Note: Reproducció del document publicat a: https://doi.org/10.3390/pharmaceutics13101652
It is part of: Pharmaceutics, 2021, vol. 13, num. 1652
URI: http://hdl.handle.net/2445/181514
Related resource: https://doi.org/10.3390/pharmaceutics13101652
ISSN: 1999-4923
Appears in Collections:Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)

Files in This Item:
File Description SizeFormat 
714860.pdf2.08 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons